Preliminary assessment of prevalence of toxoplasma in diabetic patients

154 sera of diabetic patients as well as 119 sera of healthy individuals for control were collected. Each sample was examined for toxoplasmosis using the indirect immuno fluorescence test [IFAT]. There was a statistically significant difference in the prevalence of toxoplasmosis between the diabetic group [43.5%] and the control [25.21%]. The specific IgM antibodies were negative for all of them. There was no sex predilection in either of the groups